Compare CWCO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWCO | BWAY |
|---|---|---|
| Founded | 1973 | 2003 |
| Country | Cayman Islands | Israel |
| Employees | N/A | 129 |
| Industry | Water Supply | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.1M | 547.7M |
| IPO Year | 1997 | 2011 |
| Metric | CWCO | BWAY |
|---|---|---|
| Price | $28.09 | $13.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $40.00 | $13.25 |
| AVG Volume (30 Days) | 62.0K | ★ 72.6K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $132,073,368.00 | N/A |
| Revenue This Year | $4.34 | $309.69 |
| Revenue Next Year | $42.86 | $26.21 |
| P/E Ratio | ★ $59.56 | $81.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.75 | $11.77 |
| 52 Week High | $39.12 | $26.63 |
| Indicator | CWCO | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.